In the last 12 months, insiders at Envista Holdings Corp ($NVST) filed 215 transactions with the SEC: 11 open-market purchases totaling $1,323,785 and 4 sales totaling $993,856. Net insider sentiment: net buying.
Envista Holdings Corp operates in the Dental equipment & supplies industry (Industrial Applications and Services sector).
Most Active Insiders
- Aghdaei Amir (Chief Executive Officer) — 17 transactions totaling $4,796,366
- Keel Paul A (Chief Executive Officer) — 18 transactions totaling $3,397,810
- Reis Mischa (SVP, Strategy & Bus. Dev.) — 31 transactions totaling $1,482,652
- Yu Howard H (Chief Financial Officer) — 8 transactions totaling $706,074
- Hammes Eric D. (Chief Financial Officer) — 11 transactions totaling $649,035
View all SEC Filings for Envista Holdings Corp (NVST).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | Befidi Robert | President, Diagnostics | A | Common Stock | 7605 | $0.00 | 50,932.0000 | 169,200,000 | 17.55% | 0.00% |
| Feb. 25, 2026 | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 13845 | $0.00 | 13,845.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 18020 | $0.00 | 18,020.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Keel Paul A | Chief Executive Officer | A | Common Stock | 48670 | $0.00 | 384,385.0000 | 169,200,000 | 14.50% | 0.03% |
| Feb. 25, 2026 | Nance Mark E | General Counsel | A | Common Stock | 12675 | $0.00 | 81,252.0000 | 169,200,000 | 18.48% | 0.01% |
| Feb. 25, 2026 | Nance Mark E | General Counsel | F | Common Stock | 3368 | $29.59 | 68,577.0000 | 169,200,000 | 4.68% | 0.00% |
| Feb. 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Employee Stock Option (Right to Buy) | 14020 | $0.00 | 14,020.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Performance Share Unit | 10770 | $0.00 | 10,770.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Common Stock | 5915 | $0.00 | 35,321.0000 | 169,200,000 | 20.11% | 0.00% |
| Feb. 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 2976 | $29.59 | 29,406.0000 | 169,200,000 | 9.19% | 0.00% |
| Feb. 25, 2026 | Nilsson Stefan | President, Nobel Biocare | A | Employee Stock Option (Right to Buy) | 18020 | $0.00 | 18,020.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Nilsson Stefan | President, Nobel Biocare | A | Performance Share Unit | 13845 | $0.00 | 13,845.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Nilsson Stefan | President, Nobel Biocare | A | Common Stock | 7605 | $0.00 | 62,364.0000 | 169,200,000 | 13.89% | 0.00% |
| Feb. 25, 2026 | Nilsson Stefan | President, Nobel Biocare | F | Common Stock | 182 | $29.59 | 54,759.0000 | 169,200,000 | 0.33% | 0.00% |
| Feb. 25, 2026 | Acurio Veronica | President, Orthodontics | A | Employee Stock Option (Right to Buy) | 18020 | $0.00 | 18,020.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Acurio Veronica | President, Orthodontics | A | Performance Share Unit | 13845 | $0.00 | 13,845.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Acurio Veronica | President, Orthodontics | A | Common Stock | 7605 | $0.00 | 56,516.0000 | 169,200,000 | 15.55% | 0.00% |
| Feb. 25, 2026 | Acurio Veronica | President, Orthodontics | F | Common Stock | 1412 | $29.59 | 48,911.0000 | 169,200,000 | 2.81% | 0.00% |
| Feb. 25, 2026 | Hammes Eric D. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 38040 | $0.00 | 38,040.0000 | 169,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2026 | Hammes Eric D. | Chief Financial Officer | A | Performance Share Unit | 29225 | $0.00 | 29,225.0000 | 169,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2026 | Hammes Eric D. | Chief Financial Officer | A | Common Stock | 16055 | $0.00 | 110,798.0000 | 169,200,000 | 16.95% | 0.01% |
| Feb. 25, 2026 | Hammes Eric D. | Chief Financial Officer | F | Common Stock | 2045 | $29.59 | 94,743.0000 | 169,200,000 | 2.11% | 0.00% |
| Feb. 25, 2026 | Kaabi Faez C | Chief Accounting Officer | A | Common Stock | 13520 | $0.00 | 58,552.0000 | 169,200,000 | 30.02% | 0.01% |
| Feb. 25, 2026 | Kaabi Faez C | Chief Accounting Officer | F | Common Stock | 4964 | $29.59 | 45,032.0000 | 169,200,000 | 9.93% | 0.00% |
| Feb. 25, 2026 | Keel Paul A | Chief Executive Officer | F | Common Stock | 11840 | $29.59 | 335,715.0000 | 169,200,000 | 3.41% | 0.01% |
| Feb. 25, 2026 | Nance Mark E | General Counsel | A | Employee Stock Option (Right to Buy) | 30040 | $0.00 | 30,040.0000 | 169,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2026 | Nance Mark E | General Counsel | A | Performance Share Unit | 23070 | $0.00 | 23,070.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Keel Paul A | Chief Executive Officer | A | Performance Share Unit | 132885 | $0.00 | 132,885.0000 | 169,200,000 | 9999.99% | 0.08% |
| Feb. 25, 2026 | Keel Paul A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 115320 | $0.00 | 115,320.0000 | 169,200,000 | 9999.99% | 0.07% |
| Feb. 25, 2026 | Befidi Robert | President, Diagnostics | F | Common Stock | 2177 | $29.59 | 43,327.0000 | 169,200,000 | 4.78% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | S | Common Stock | 4041 | $30.00 | 32,382.0000 | 169,200,000 | 11.09% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | M | Employee Stock Option (Right to Buy) | 5634 | $0.00 | 0.0000 | 169,200,000 | 100.00% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | M | Employee Stock Option (Right to Buy) | 4041 | $0.00 | 0.0000 | 169,200,000 | 100.00% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | S | Common Stock | 5634 | $30.00 | 32,382.0000 | 169,200,000 | 14.82% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | M | Common Stock | 4041 | $19.04 | 36,423.0000 | 169,200,000 | 12.48% | 0.00% |
| Feb. 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | M | Common Stock | 5634 | $15.97 | 38,016.0000 | 169,200,000 | 17.40% | 0.00% |
| Feb. 1, 2026 | Keel Paul A | Chief Executive Officer | A | Envista deferred contribution programs - Envista Stock Fund | 4091 | $23.47 | 4,091.0000 | 169,200,000 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Nance Mark E | General Counsel | A | Envista deferred contribution programs - Envista Stock Fund | 2006 | $23.47 | 7,587.0000 | 169,200,000 | 35.94% | 0.00% |
| Feb. 1, 2026 | Kaabi Faez C | Chief Accounting Officer | A | Envista deferred contribution programs - Envista Stock Fund | 1186 | $23.47 | 5,040.0000 | 169,200,000 | 30.77% | 0.00% |
| Feb. 1, 2026 | Acurio Veronica | President, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 998 | $23.47 | 998.0000 | 169,200,000 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Hammes Eric D. | Chief Financial Officer | A | Envista deferred contribution programs - Envista Stock Fund | 1119 | $23.47 | 1,119.0000 | 169,200,000 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Executive Deferred Incentive Program - Envista Stock Fund | 2919 | $21.71 | 29,357.0000 | 169,200,000 | 11.04% | 0.00% |
| Feb. 1, 2026 | Befidi Robert | President, Diagnostics | A | Envista deferred contribution programs - Envista Stock Fund | 998 | $23.47 | 2,149.0000 | 169,200,000 | 86.71% | 0.00% |
| Nov. 1, 2025 | Keel Paul A | Chief Executive Officer | F | Common Stock | 54097 | $20.35 | 347,555.0000 | 170,300,000 | 13.47% | 0.03% |
| Aug. 25, 2025 | Hammes Eric D. | Chief Financial Officer | F | Common Stock | 7654 | $21.12 | 96,788.0000 | 172,200,000 | 7.33% | 0.00% |
| Aug. 25, 2025 | Nilsson Stefan | President, Nobel Biocare | F | Common Stock | 804 | $21.12 | 54,941.0000 | 172,200,000 | 1.44% | 0.00% |
| Aug. 25, 2025 | Acurio Veronica | President, Orthodontics | F | Common Stock | 5422 | $21.12 | 50,323.0000 | 172,200,000 | 9.73% | 0.00% |
| Aug. 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | S | Common Stock | 15000 | $21.60 | 32,382.0000 | 172,200,000 | 31.66% | 0.01% |
| Aug. 25, 2025 | Befidi Robert | President, Diagnostics | F | Common Stock | 3454 | $21.12 | 45,504.0000 | 172,200,000 | 7.06% | 0.00% |
| July 14, 2025 | Pierce James Andrew | Director | A | Common Stock | 9155 | $0.00 | 9,155.0000 | 172,200,000 | 9999.99% | 0.01% |
| June 10, 2025 | TSINGOS CHRISTINE A | Director | A | Common Stock | 10450 | $0.00 | 50,600.0000 | 172,200,000 | 26.03% | 0.01% |
| June 10, 2025 | Carruthers Wendy | Director | A | Common Stock | 10450 | $0.00 | 50,610.0000 | 172,200,000 | 26.02% | 0.01% |
| June 10, 2025 | Huennekens R Scott | Director | A | Common Stock | 14370 | $0.00 | 69,520.0000 | 172,200,000 | 26.06% | 0.01% |
| June 10, 2025 | Jain Vivek | Director | A | Common Stock | 10450 | $0.00 | 43,615.0000 | 172,200,000 | 31.51% | 0.01% |
| June 10, 2025 | Raskas Daniel | Director | A | Common Stock | 10450 | $0.00 | 44,680.0000 | 172,200,000 | 30.53% | 0.01% |
| June 10, 2025 | GALLAHUE KIERAN | Director | A | Common Stock | 10450 | $0.00 | 44,680.0000 | 172,200,000 | 30.53% | 0.01% |
| June 10, 2025 | Hulit Barbara B. | Director | A | Common Stock | 10450 | $0.00 | 79,820.0000 | 172,200,000 | 15.06% | 0.01% |
| May 25, 2025 | Keel Paul A | Chief Executive Officer | F | Common Stock | 12787 | $16.72 | 401,652.0000 | 172,200,000 | 3.09% | 0.01% |
| Feb. 25, 2025 | Nilsson Stefan | President, Nobel Biocare | A | Performance Share Unit | 18960 | $0.00 | 18,960.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Kaabi Faez C | Chief Accounting Officer | F | Common Stock | 4319 | $20.66 | 40,311.0000 | 172,200,000 | 9.68% | 0.00% |
| Feb. 25, 2025 | Kaabi Faez C | Chief Accounting Officer | A | Common Stock | 9685 | $0.00 | 49,996.0000 | 172,200,000 | 24.03% | 0.01% |
| Feb. 25, 2025 | Kaabi Faez C | Chief Accounting Officer | A | Employee Stock Option (Right to Buy) | 22600 | $0.00 | 22,600.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 3813 | $20.66 | 38,907.0000 | 172,200,000 | 8.93% | 0.00% |
| Feb. 26, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Common Stock | 8475 | $0.00 | 47,382.0000 | 172,200,000 | 21.78% | 0.00% |
| Feb. 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Performance Share Unit | 15615 | $0.00 | 15,615.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Employee Stock Option (Right to Buy) | 19780 | $0.00 | 19,780.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Keel Paul A | Chief Executive Officer | A | Common Stock | 65830 | $0.00 | 414,439.0000 | 172,200,000 | 18.88% | 0.04% |
| Feb. 25, 2025 | Keel Paul A | Chief Executive Officer | A | Performance Share Unit | 181985 | $0.00 | 181,985.0000 | 172,200,000 | 9999.99% | 0.11% |
| Feb. 25, 2025 | Keel Paul A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 153660 | $0.00 | 153,660.0000 | 172,200,000 | 9999.99% | 0.09% |
| Feb. 25, 2025 | Acurio Veronica | President, Orthodontics | A | Common Stock | 10290 | $0.00 | 55,745.0000 | 172,200,000 | 22.64% | 0.01% |
| Feb. 25, 2025 | Acurio Veronica | President, Orthodontics | A | Performance Share Unit | 18960 | $0.00 | 18,960.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Acurio Veronica | President, Orthodontics | A | Employee Stock Option (Right to Buy) | 24010 | $0.00 | 24,010.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Nilsson Stefan | President, Nobel Biocare | A | Common Stock | 10290 | $0.00 | 55,745.0000 | 172,200,000 | 22.64% | 0.01% |
| Feb. 25, 2025 | Nilsson Stefan | President, Nobel Biocare | A | Employee Stock Option (Right to Buy) | 24010 | $0.00 | 24,010.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Befidi Robert | President, Diagnostics | F | Common Stock | 1123 | $20.66 | 38,668.0000 | 172,200,000 | 2.82% | 0.00% |
| Feb. 25, 2025 | Befidi Robert | President, Diagnostics | A | Common Stock | 10290 | $0.00 | 48,958.0000 | 172,200,000 | 26.61% | 0.01% |
| Feb. 25, 2025 | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 18960 | $0.00 | 18,960.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 24010 | $0.00 | 24,010.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Hammes Eric D. | Chief Financial Officer | A | Common Stock | 15735 | $0.00 | 104,442.0000 | 172,200,000 | 17.74% | 0.01% |
| Feb. 25, 2025 | Hammes Eric D. | Chief Financial Officer | A | Performance Share Unit | 28995 | $0.00 | 28,995.0000 | 172,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2025 | Hammes Eric D. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 36720 | $0.00 | 36,720.0000 | 172,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2025 | Nance Mark E | General Counsel | F | Common Stock | 3691 | $20.66 | 53,790.0000 | 172,200,000 | 6.42% | 0.00% |
| Feb. 25, 2025 | Nance Mark E | General Counsel | A | Common Stock | 18155 | $0.00 | 71,945.0000 | 172,200,000 | 33.75% | 0.01% |
| Feb. 25, 2025 | Nance Mark E | General Counsel | A | Performance Share Unit | 33455 | $0.00 | 33,455.0000 | 172,200,000 | 9999.99% | 0.02% |
| Feb. 25, 2025 | Nance Mark E | General Counsel | A | Employee Stock Option (Right to Buy) | 42370 | $0.00 | 42,370.0000 | 172,200,000 | 9999.99% | 0.02% |
| Feb. 1, 2025 | Nance Mark E | General Counsel | A | Envista deferred contribution programs - Envista Stock Fund | 965 | $20.52 | 5,581.0000 | 172,200,000 | 20.91% | 0.00% |
| Feb. 1, 2025 | Kaabi Faez C | Chief Accounting Officer | A | Envista deferred contribution programs - Envista Stock Fund | 689 | $20.52 | 3,854.0000 | 172,200,000 | 21.77% | 0.00% |
| Feb. 1, 2025 | Befidi Robert | President, Diagnostics | A | Envista deferred contribution programs - Envista Stock Fund | 1151 | $20.52 | 1,151.0000 | 172,200,000 | 9999.99% | 0.00% |
| Feb. 1, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Executive Deferred Incentive Program - Envista Stock Fund | 3152 | $20.52 | 26,438.0000 | 172,200,000 | 13.54% | 0.00% |
| Nov. 1, 2024 | Keel Paul A | Chief Executive Officer | F | Common Stock | 53996 | $20.94 | 348,609.0000 | 172,900,000 | 13.41% | 0.03% |
| Sept. 17, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 812 | $19.00 | 42,720.0000 | 166,900,000 | 1.87% | 0.00% |
| Aug. 25, 2024 | Keel Paul A | Chief Executive Officer | A | Performance Option | 485680 | $0.00 | 485,680.0000 | 166,900,000 | 9999.99% | 0.29% |
| Aug. 25, 2024 | Hammes Eric D. | Chief Financial Officer | A | Common Stock | 64175 | $0.00 | 88,707.0000 | 166,900,000 | 261.60% | 0.04% |
| Aug. 25, 2024 | Befidi Robert | President, Diagnostics | A | Performance Option | 70400 | $0.00 | 70,400.0000 | 166,900,000 | 9999.99% | 0.04% |
| Aug. 25, 2024 | Befidi Robert | President, Diagnostics | F | Common Stock | 3454 | $18.70 | 39,791.0000 | 166,900,000 | 7.99% | 0.00% |
| Aug. 25, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Performance Option | 57980 | $0.00 | 57,980.0000 | 166,900,000 | 9999.99% | 0.03% |
| Aug. 25, 2024 | Nance Mark E | General Counsel | A | Performance Option | 95240 | $0.00 | 95,240.0000 | 166,900,000 | 9999.99% | 0.06% |
| Aug. 13, 2024 | Keel Paul A | Chief Executive Officer | P | Common Stock | 30000 | $16.87 | 402,605.0000 | 166,900,000 | 8.05% | 0.02% |
| Aug. 12, 2024 | Hammes Eric D. | Chief Financial Officer | P | Common Stock | 24532 | $16.33 | 24,532.0000 | 166,900,000 | 9999.99% | 0.01% |
| July 15, 2024 | Nance Mark E | General Counsel | F | Common Stock | 491 | $15.94 | 57,481.0000 | 166,900,000 | 0.85% | 0.00% |
| June 25, 2024 | Keller Stephen | Principal Financial Officer | A | Common Stock | 31250 | $0.00 | 53,803.0000 | 166,900,000 | 138.56% | 0.02% |
| May 25, 2024 | Conley Eric | SVP, Orthodontics | F | Common Stock | 642 | $18.25 | 53,223.0000 | 166,900,000 | 1.19% | 0.00% |
| May 25, 2024 | Keel Paul A | Chief Executive Officer | A | Common Stock | 71235 | $0.00 | 71,235.0000 | 166,900,000 | 9999.99% | 0.04% |
| May 25, 2024 | Keel Paul A | Chief Executive Officer | A | Performance Share Unit | 205265 | $0.00 | 205,265.0000 | 166,900,000 | 9999.99% | 0.12% |
| May 25, 2024 | Keel Paul A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 164560 | $0.00 | 164,560.0000 | 166,900,000 | 9999.99% | 0.10% |
| May 25, 2024 | Keel Paul A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 696210 | $0.00 | 696,210.0000 | 166,900,000 | 9999.99% | 0.42% |
| May 25, 2024 | Keel Paul A | Chief Executive Officer | A | Common Stock | 301370 | $0.00 | 372,605.0000 | 166,900,000 | 423.06% | 0.18% |
| May 21, 2024 | GALLAHUE KIERAN | Director | A | Common Stock | 10085 | $0.00 | 34,230.0000 | 166,900,000 | 41.77% | 0.01% |
| May 21, 2024 | Carruthers Wendy | Director | A | Common Stock | 10085 | $0.00 | 40,160.0000 | 166,900,000 | 33.53% | 0.01% |
| May 21, 2024 | TSINGOS CHRISTINE A | Director | A | Common Stock | 10085 | $0.00 | 40,150.0000 | 166,900,000 | 33.54% | 0.01% |
| May 21, 2024 | Jain Vivek | Director | A | Common Stock | 10085 | $0.00 | 33,165.0000 | 166,900,000 | 43.70% | 0.01% |
| May 21, 2024 | Huennekens R Scott | Director | A | Common Stock | 14170 | $0.00 | 55,150.0000 | 166,900,000 | 34.58% | 0.01% |
| May 21, 2024 | Hulit Barbara B. | Director | A | Common Stock | 10085 | $0.00 | 69,370.0000 | 166,900,000 | 17.01% | 0.01% |
| May 21, 2024 | Raskas Daniel | Director | A | Common Stock | 10085 | $0.00 | 34,230.0000 | 166,900,000 | 41.77% | 0.01% |
| April 15, 2024 | Hulit Barbara B. | Director | A | Common Stock | 13065 | $0.00 | 59,285.0000 | 166,900,000 | 28.27% | 0.01% |
| March 15, 2024 | Hulit Barbara B. | Director | A | Common Stock | 11705 | $0.00 | 46,220.0000 | 166,900,000 | 33.91% | 0.01% |
| Feb. 25, 2024 | Aghdaei Amir | Chief Executive Officer | A | Performance Share Unit | 133985 | $0.00 | 133,985.0000 | 166,900,000 | 9999.99% | 0.08% |
| Feb. 25, 2024 | Keller Stephen | Principal Financial Officer | A | Common Stock | 11045 | $0.00 | 22,553.0000 | 166,900,000 | 95.98% | 0.01% |
| Feb. 25, 2024 | Keller Stephen | Principal Financial Officer | A | Employee Stock Option (Right to Buy) | 15460 | $0.00 | 15,460.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 4134 | $22.65 | 26,967.0000 | 166,900,000 | 13.29% | 0.00% |
| Feb. 25, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Common Stock | 16565 | $0.00 | 43,532.0000 | 166,900,000 | 61.43% | 0.01% |
| Feb. 25, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Performance Share Unit | 14215 | $0.00 | 14,215.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Employee Stock Option (Right to Buy) | 18040 | $0.00 | 18,040.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Befidi Robert | President, Diagnostics | A | Common Stock | 9385 | $0.00 | 43,245.0000 | 166,900,000 | 27.72% | 0.01% |
| Feb. 25, 2024 | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 17260 | $0.00 | 17,260.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 21910 | $0.00 | 21,910.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Conley Eric | SVP, Orthodontics | F | Common Stock | 1241 | $22.65 | 46,135.0000 | 166,900,000 | 2.62% | 0.00% |
| Feb. 25, 2024 | Conley Eric | SVP, Orthodontics | A | Common Stock | 7730 | $0.00 | 53,865.0000 | 166,900,000 | 16.76% | 0.00% |
| Feb. 25, 2024 | Conley Eric | SVP, Orthodontics | A | Performance Share Unit | 14215 | $0.00 | 14,215.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Conley Eric | SVP, Orthodontics | A | Employee Stock Option (Right to Buy) | 18040 | $0.00 | 18,040.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Aghdaei Amir | Chief Executive Officer | F | Common Stock | 33367 | $22.65 | 261,995.0000 | 166,900,000 | 11.30% | 0.02% |
| Feb. 25, 2024 | Aghdaei Amir | Chief Executive Officer | A | Common Stock | 48570 | $0.00 | 310,565.0000 | 166,900,000 | 18.54% | 0.03% |
| Feb. 25, 2024 | Aghdaei Amir | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 113370 | $0.00 | 113,370.0000 | 166,900,000 | 9999.99% | 0.07% |
| Feb. 25, 2024 | Kaabi Faez C | Chief Accounting Officer | F | Common Stock | 1505 | $22.65 | 13,715.0000 | 166,900,000 | 9.89% | 0.00% |
| Feb. 25, 2024 | Kaabi Faez C | Chief Accounting Officer | A | Common Stock | 30915 | $0.00 | 44,630.0000 | 166,900,000 | 225.41% | 0.02% |
| Feb. 25, 2024 | Kaabi Faez C | Chief Accounting Officer | A | Employee Stock Option (Right to Buy) | 20620 | $0.00 | 20,620.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Nance Mark E | General Counsel | F | Common Stock | 2600 | $22.65 | 36,442.0000 | 166,900,000 | 6.66% | 0.00% |
| Feb. 25, 2024 | Nance Mark E | General Counsel | A | Common Stock | 21530 | $0.00 | 57,972.0000 | 166,900,000 | 59.08% | 0.01% |
| Feb. 25, 2024 | Nance Mark E | General Counsel | A | Performance Share Unit | 23350 | $0.00 | 23,350.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Nance Mark E | General Counsel | A | Employee Stock Option (Right to Buy) | 29640 | $0.00 | 29,640.0000 | 166,900,000 | 9999.99% | 0.02% |
| Feb. 25, 2024 | Keller Stephen | Principal Financial Officer | F | Common Stock | 1562 | $22.65 | 11,508.0000 | 166,900,000 | 11.95% | 0.00% |
| Feb. 15, 2024 | Hulit Barbara B. | Director | A | Common Stock | 22225 | $0.00 | 34,515.0000 | 166,900,000 | 180.84% | 0.01% |
| Feb. 1, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Executive Deferred Incentive Program - Envista Stock Fund | 2528 | $23.74 | 23,286.0000 | 166,900,000 | 12.18% | 0.00% |
| Feb. 1, 2024 | Aghdaei Amir | Chief Executive Officer | A | Executive Deferred Incentive Program - Envista Stock Fund | 10287 | $23.74 | 86,300.0000 | 166,900,000 | 13.53% | 0.01% |
| Feb. 1, 2024 | Nance Mark E | General Counsel | A | Envista deferred contribution programs - Envista Stock Fund | 1498 | $23.74 | 4,616.0000 | 166,900,000 | 48.04% | 0.00% |
| Feb. 1, 2024 | Conley Eric | SVP, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 1219 | $23.74 | 4,706.0000 | 166,900,000 | 34.96% | 0.00% |
| Feb. 1, 2024 | Kaabi Faez C | Chief Accounting Officer | A | Envista deferred contribution programs - Envista Stock Fund | 754 | $23.74 | 3,165.0000 | 166,900,000 | 31.27% | 0.00% |
| Feb. 1, 2024 | Keller Stephen | Principal Financial Officer | A | Envista deferred contribution programs - Envista Stock Fund | 548 | $23.74 | 1,759.0000 | 166,900,000 | 45.25% | 0.00% |
| Nov. 16, 2023 | Conley Eric | SVP, Orthodontics | P | Common Stock | 2182 | $22.89 | 47,373.0000 | 177,600,000 | 4.83% | 0.00% |
| Nov. 16, 2023 | Conley Eric | SVP, Orthodontics | P | Common Stock | 2 | $22.90 | 47,376.0000 | 177,600,000 | 0.00% | 0.00% |
| Nov. 16, 2023 | Conley Eric | SVP, Orthodontics | P | Common Stock | 1 | $22.90 | 47,374.0000 | 177,600,000 | 0.00% | 0.00% |
| Nov. 8, 2023 | Nance Mark E | General Counsel | P | Common Stock | 5000 | $21.75 | 39,042.0000 | 177,600,000 | 14.69% | 0.00% |
| Nov. 6, 2023 | Aghdaei Amir | Chief Executive Officer | P | Common Stock | 600 | $21.52 | 293,764.0000 | 177,600,000 | 0.20% | 0.00% |
| Nov. 6, 2023 | Aghdaei Amir | Chief Executive Officer | P | Common Stock | 701 | $21.51 | 294,465.0000 | 177,600,000 | 0.24% | 0.00% |
| Nov. 6, 2023 | Aghdaei Amir | Chief Executive Officer | P | Common Stock | 7802 | $21.53 | 293,164.0000 | 177,600,000 | 2.73% | 0.00% |
| Nov. 6, 2023 | Keller Stephen | Principal Financial Officer | P | Common Stock | 2000 | $21.53 | 13,070.0000 | 177,600,000 | 18.07% | 0.00% |
| Nov. 6, 2023 | Aghdaei Amir | Chief Executive Officer | P | Common Stock | 897 | $21.50 | 295,362.0000 | 177,600,000 | 0.30% | 0.00% |
| Sept. 17, 2023 | Eriksson Patrik | Senior Vice President | F | Common Stock | 1298 | $28.87 | 79,686.0000 | 177,600,000 | 1.60% | 0.00% |
| Sept. 17, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 787 | $28.87 | 31,101.0000 | 177,600,000 | 2.47% | 0.00% |
| Sept. 17, 2023 | Yu Howard H | Chief Financial Officer | F | Common Stock | 1965 | $28.87 | 43,900.0000 | 177,600,000 | 4.28% | 0.00% |
| Sept. 17, 2023 | Aghdaei Amir | Chief Executive Officer | F | Common Stock | 18394 | $28.87 | 285,362.0000 | 177,600,000 | 6.06% | 0.01% |
| July 15, 2023 | Nance Mark E | General Counsel | F | Common Stock | 492 | $35.07 | 34,042.0000 | 177,600,000 | 1.42% | 0.00% |
| July 15, 2023 | Aghdaei Amir | Chief Executive Officer | F | Common Stock | 13250 | $35.07 | 303,756.0000 | 177,600,000 | 4.18% | 0.01% |
| May 25, 2023 | Conley Eric | SVP, Orthodontics | F | Common Stock | 642 | $32.95 | 45,191.0000 | 177,600,000 | 1.40% | 0.00% |
| May 23, 2023 | Carruthers Wendy | Director | A | Common Stock | 5425 | $0.00 | 30,075.0000 | 177,600,000 | 22.01% | 0.00% |
| May 23, 2023 | GALLAHUE KIERAN | Director | A | Common Stock | 5425 | $0.00 | 24,145.0000 | 177,600,000 | 28.98% | 0.00% |
| May 23, 2023 | Jain Vivek | Director | A | Common Stock | 5425 | $0.00 | 23,080.0000 | 177,600,000 | 30.73% | 0.00% |
| May 23, 2023 | Huennekens R Scott | Director | A | Common Stock | 7625 | $0.00 | 40,980.0000 | 177,600,000 | 22.86% | 0.00% |
| May 23, 2023 | TSINGOS CHRISTINE A | Director | A | Common Stock | 5425 | $0.00 | 30,065.0000 | 177,600,000 | 22.02% | 0.00% |
| May 23, 2023 | Hulit Barbara B. | Director | A | Common Stock | 5425 | $0.00 | 12,290.0000 | 177,600,000 | 79.02% | 0.00% |
| May 23, 2023 | Raskas Daniel | Director | A | Common Stock | 5425 | $0.00 | 24,145.0000 | 177,600,000 | 28.98% | 0.00% |
| May 12, 2023 | Conley Eric | SVP, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 9 | $33.05 | 3,487.0000 | 177,600,000 | 0.26% | 0.00% |
| April 28, 2023 | Conley Eric | SVP, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 8 | $38.49 | 3,478.0000 | 177,600,000 | 0.23% | 0.00% |
| April 14, 2023 | Conley Eric | SVP, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 0 | $37.66 | 3,470.0000 | 177,600,000 | 0.00% | 0.00% |
| April 4, 2023 | Aghdaei Amir | Chief Executive Officer | A | Executive Deferred Incentive Program - Envista Stock Fund | 5881 | $38.73 | 76,013.0000 | 177,600,000 | 8.39% | 0.00% |
| April 4, 2023 | Kyrillos Jean-Claude | Senior Vice President | A | Envista deferred contribution programs - Envista Stock Fund | 516 | $38.73 | 1,431.0000 | 177,600,000 | 56.39% | 0.00% |
| April 4, 2023 | Nance Mark E | General Counsel | A | Envista deferred contribution programs - Envista Stock Fund | 1308 | $38.73 | 3,118.0000 | 177,600,000 | 72.27% | 0.00% |
| April 4, 2023 | Conley Eric | SVP, Orthodontics | A | Envista deferred contribution programs - Envista Stock Fund | 928 | $38.73 | 3,462.0000 | 177,600,000 | 36.62% | 0.00% |
| April 4, 2023 | Yu Howard H | Chief Financial Officer | A | Envista deferred contribution programs - Envista Stock Fund | 1513 | $38.73 | 3,871.0000 | 177,600,000 | 64.16% | 0.00% |
| April 4, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Executive Deferred Incentive Program - Envista Stock Fund | 1730 | $38.73 | 20,758.0000 | 177,600,000 | 9.09% | 0.00% |
| April 4, 2023 | Eriksson Patrik | Senior Vice President | A | Executive Deferred Incentive Program - Envista Stock Fund | 2222 | $38.73 | 42,099.0000 | 177,600,000 | 5.57% | 0.00% |
| Feb. 28, 2023 | Yu Howard H | Chief Financial Officer | S | Common Stock | 10016 | $37.90 | 45,865.0000 | 177,600,000 | 17.92% | 0.01% |
| Feb. 25, 2023 | Eriksson Patrik | Senior Vice President | F | Common Stock | 2907 | $38.25 | 75,424.0000 | 177,600,000 | 3.71% | 0.00% |
| Feb. 24, 2023 | Eriksson Patrik | Senior Vice President | F | Common Stock | 3414 | $38.25 | 78,331.0000 | 177,600,000 | 4.18% | 0.00% |
| Feb. 25, 2023 | Yu Howard H | Chief Financial Officer | A | Performance Share Unit | 18705 | $0.00 | 18,705.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Yu Howard H | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 24710 | $0.00 | 24,710.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Yu Howard H | Chief Financial Officer | A | Common Stock | 10295 | $0.00 | 55,881.0000 | 177,600,000 | 22.58% | 0.01% |
| Feb. 25, 2023 | Yu Howard H | Chief Financial Officer | F | Common Stock | 3717 | $38.25 | 45,586.0000 | 177,600,000 | 7.54% | 0.00% |
| Feb. 25, 2023 | Conley Eric | SVP, Orthodontics | A | Common Stock | 16995 | $0.00 | 45,833.0000 | 177,600,000 | 58.93% | 0.01% |
| Feb. 25, 2023 | Aghdaei Amir | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 65250 | $0.00 | 65,250.0000 | 177,600,000 | 9999.99% | 0.04% |
| Feb. 25, 2023 | Aghdaei Amir | Chief Executive Officer | A | Performance Share Unit | 74095 | $0.00 | 74,095.0000 | 177,600,000 | 9999.99% | 0.04% |
| Feb. 25, 2023 | Aghdaei Amir | Chief Executive Officer | A | Common Stock | 27190 | $0.00 | 317,006.0000 | 177,600,000 | 9.38% | 0.02% |
| Feb. 25, 2023 | Aghdaei Amir | Chief Executive Officer | F | Common Stock | 23517 | $38.25 | 289,816.0000 | 177,600,000 | 7.51% | 0.01% |
| Feb. 24, 2023 | Aghdaei Amir | Chief Executive Officer | F | Common Stock | 38121 | $38.25 | 313,333.0000 | 177,600,000 | 10.85% | 0.02% |
| Feb. 24, 2023 | Yu Howard H | Chief Financial Officer | F | Common Stock | 1803 | $38.25 | 49,303.0000 | 177,600,000 | 3.53% | 0.00% |
| Feb. 25, 2023 | Conley Eric | SVP, Orthodontics | A | Employee Stock Option (Right to Buy) | 10980 | $0.00 | 10,980.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Conley Eric | SVP, Orthodontics | A | Performance Share Unit | 8315 | $0.00 | 8,315.0000 | 177,600,000 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Kyrillos Jean-Claude | Senior Vice President | F | Common Stock | 2796 | $38.25 | 22,278.0000 | 177,600,000 | 11.15% | 0.00% |
| Feb. 25, 2023 | Kyrillos Jean-Claude | Senior Vice President | A | Common Stock | 5560 | $0.00 | 27,838.0000 | 177,600,000 | 24.96% | 0.00% |
| Feb. 25, 2023 | Kyrillos Jean-Claude | Senior Vice President | A | Employee Stock Option (Right to Buy) | 13340 | $0.00 | 13,340.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Kyrillos Jean-Claude | Senior Vice President | A | Performance Share Unit | 10095 | $0.00 | 10,095.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Nance Mark E | General Counsel | F | Common Stock | 2021 | $38.25 | 28,324.0000 | 177,600,000 | 6.66% | 0.00% |
| Feb. 25, 2023 | Nance Mark E | General Counsel | A | Common Stock | 6210 | $0.00 | 34,534.0000 | 177,600,000 | 21.92% | 0.00% |
| Feb. 25, 2023 | Nance Mark E | General Counsel | A | Employee Stock Option (Right to Buy) | 14910 | $0.00 | 14,910.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Nance Mark E | General Counsel | A | Performance Share Unit | 11280 | $0.00 | 11,280.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Conley Eric | SVP, Orthodontics | A | Common Stock | 4580 | $0.00 | 28,838.0000 | 177,600,000 | 18.88% | 0.00% |
| Feb. 25, 2023 | Conley Eric | SVP, Orthodontics | F | Common Stock | 630 | $38.25 | 24,258.0000 | 177,600,000 | 2.53% | 0.00% |
| Feb. 25, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Performance Share Unit | 8315 | $0.00 | 8,315.0000 | 177,600,000 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Employee Stock Option (Right to Buy) | 10980 | $0.00 | 10,980.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | A | Common Stock | 4580 | $0.00 | 31,888.0000 | 177,600,000 | 16.77% | 0.00% |
| Feb. 25, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 1951 | $38.25 | 27,308.0000 | 177,600,000 | 6.67% | 0.00% |
| Feb. 24, 2023 | Reis Mischa | SVP, Strategy & Bus. Dev. | F | Common Stock | 1913 | $38.25 | 29,259.0000 | 177,600,000 | 6.14% | 0.00% |
| Feb. 25, 2023 | Eriksson Patrik | Senior Vice President | A | Performance Share Unit | 10095 | $0.00 | 10,095.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Eriksson Patrik | Senior Vice President | A | Employee Stock Option (Right to Buy) | 13340 | $0.00 | 13,340.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Eriksson Patrik | Senior Vice President | A | Common Stock | 5560 | $0.00 | 80,984.0000 | 177,600,000 | 7.37% | 0.00% |